Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AfterDmab: Zoledronic Acid After Denosumab
NCT02499237Phase 4Completed
- Sponsor
- 424 General Military Hospital
- Start
- Jul 2015
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of zoledronic acid in postmenopausal osteoporosis, sponsored by 424 General Military Hospital. Started Jul 2015; status: completed.
02
Drugs
zoledronic acid
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT02499237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02499237.